Reference
Chakrabarti A, et al. Bevacizumab and capecitabine in relapsed platinum-resistant epithelial carcinoma of ovary: A retrospective study. Clinical Cancer Investigation Journal 8: 84-89, No. 3, Jun 2019. Available from: URL: http://doi.org/10.4103/ccij.ccij_31_19
Rights and permissions
About this article
Cite this article
Bevacizumab/capecitabine. Reactions Weekly 1810, 50 (2020). https://doi.org/10.1007/s40278-020-80070-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-80070-1